2026-10-09 · equities

Form 4 PTC Therapeutics Inc For: 9 October

Source Investing.com UK Equities

The partnership's sales were made under a written Rule 10b5-1 plan adopted May 14, 2026.

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Rhea-AI Filing Summary

PTC Therapeutics, Inc. (PTCT) director Michael Schmertzler reported that Section Six Partners, L.P., of which he is a general and limited partner, sold 2,500 common shares in two transactions on October 7, 2026: 2,447 shares at a weighted average $63.38 per share and 53 shares at $63.95. The 2,447-share price reflects multiple trades ranging from $62.89 to $63.88. Both sales were made under the partnership's written Rule 10b5-1 plan adopted May 14, 2026. The shares were held by the partnership; Schmertzler disclaims beneficial ownership except to the extent of his pecuniary interest. A separate entry lists 163,266 shares held directly.

Insider Trade Summary 10b5-1

Footnotes (3)

• F1. This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by Section Six Partners, L.P., of which the Reporting Person is a general partner and limited partner, on May 14, 2026.
• F2. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $62.89 to $63.88 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
• F3. Represents shares of common stock held by Section Six Partners, L.P. The Reporting Person is a general and limited partner of Section Six Partners, L.P. The Reporting Person disclaims beneficial ownership of the shares of common stock held by Section Six Partners, L.P. except to the extent of his pecuniary interest therein.

Key Figures

Key Terms

Rule 10b5-1 plan regulatory

weighted average price financial

beneficial ownership regulatory

pecuniary interest financial

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

AI-generated analysis. How Rhea-AI works. Not financial advice.